Business

Oxford Biomedica PLC - General Meeting

Oxford Biomedica PLC - General Meeting.

articleOxford Biomedica PlcJanuary 6, 20145/company/oxford-biomedica-plc/news/oxford-biomedica-plc-general-meeting
Oxford Biomedica PLC - General Meeting

About this update from Oxford Biomedica Plc

[{"type":"text","content":"\n \nRNS Number : 9618W Oxford Biomedica PLC 06 January 2014  \n \n\n\n\n\n\nFOR IMMEDIATE RELEASE\n\n\n \n\n\n\n\n                                               \nOXFORD BIOMEDICA PLC\nGENERAL MEETING\n \nOxford, UK - 6 January 2014: Oxford BioMedica plc (\"Oxford BioMedica\" or \"the Company\") (LSE: OXB), the leading gene-based biopharmaceutical company, announced the results of its General Meeting held today in London.  In accordance with Listing Rule 9.6.18, the following resolution was passed at the meeting:\n \nResolution 1: THAT, the entry by the Company into the proposed secured Loan Facility of up to £5 million with Vulpes Life Sciences Fund, being a related party transaction for the purposes of the Listing Rules, be and is hereby approved.\n \nThe full text of the Shareholder Circular and the Notice of Meeting can be viewed by visiting the Company's website at www.oxfordbiomedica.co.uk.\n \nCertified copies of the document setting out the above resolution passed at this General Meeting have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do.\n \nThe results of the proxy voting in advance of the meeting are shown below.\n \n\n\n\n\n \n \nResolution\n\n\n \nVotes \nFor\n\n\nVotes at \nChairman's\nDiscretion\n\n\nVotes at \nother proxy\nDiscretion\n\n\n \n Votes\nAgainst\n\n\n \nVotes \nWithheld\n\n\n \nTotal\nvotes cast\n\n\nResult\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n1\n\n\n331,276,628\n\n\n1,016,145\n\n\n981,574\n\n\n718,232\n\n\n716,075\n\n\n334,708,654\n\n\nApproved\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n-Ends-\n \n\n\n\n\nFor further information, please contact:\n\n\n \n\n\n\n\nOxford BioMedica plc:\nTim Watts, Chief Financial Officer\n\n\nTel: +44 (0)1865 783 000\n\n\n\n\n \nMedia Enquiries:\nMary-Jane Elliott/Emma Thompson/Matthew Neal\nConsilium Strategic Communications\n\n\n \n \nTel:...

More updates from Oxford Biomedica Plc